glp 1 renal impairment effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine Kidney Outcomes With Glucagon-Like Peptide-1
Description
On June 23, 2025, Eli Lilly presented Phase 2b clinical data on Bimagrumab for weight loss at the ADA conference
It sets a new precedent for curbing appetite and burning fat
Ready to get started
Serena Williams broke her silence about her weight loss journey, revealing she used medication to help her lose 31 pounds.
Manuj Sondhi, MRCP (UK), Greater Noida.
Despite these risks, intentional preoperative weight optimization is not routinely incorporated into CRC management, owing to concerns regarding treatment delay, absence of guideline endorsement, and limited supporting evidence
